Delivery Order SPE2DB20D9214-SPE2DB24FD4WU

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,614.80, is for the delivery of BOTOX 100 unit vials to support the recurring pharmaceutical supply needs of military health facilities. The order is part of a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which runs through December 31, 2025. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 200-unit vials of the pharmaceutical Botox, with a ceiling value of $47,674.50 and a completion date of September 22, 2021. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA,...
This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of BOTOX 100 unit vials to the Department of Defense (DoD). The contract, which is a firm fixed-price delivery order, has a ceiling value of $4,614.80 and an ultimate completion date of October 11, 2024. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is not set aside and is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,614.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of BOTOX. This order is placed under DMS Pharmaceutical Group's existing indefinite-delivery, indefinite-quantity (IDIQ) contract SPE2DB, valued at up to $4,999,999 through 2025, which allows DLA to issue delivery orders for a broad range of pharmaceutical products to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,537.76 award is for the delivery of 100-unit vials of Botox. The contract has a ceiling value of $5,537.76 and an ultimate completion date of December 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,562,472,907 units of BOTOX 200 unit vials. The contract, which has an ultimate completion date of November 3, 2023, has a ceiling value of $15,524.40. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB22D9362 with DLA, which allows the agency to order a broad range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,537.76, is for the delivery of 100-unit vials of the pharmaceutical product Botox. The contract is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999, which allows the DLA to...
The U.S. Department of Defense (DoD) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,460.72 contract, with an ultimate completion date of October 2, 2024, is for the supply of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4WU
    Delivery Order

This firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) on September 12, 2024, is for the supply of 100-unit vials of Botox (Botulinum Toxin Type A) to the U.S. Department of Defense (DoD). The contract has a ceiling value of $5,537.76 and an ultimate completion date of October 3, 2024. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which covers a wide range of pharmaceutical items to support the medical supply needs of DoD healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 12/12/24, 9:03 AM